How should I write a prescription for vitamin K (phytonadione) 3 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Write a Prescription for Vitamin K (Phytonadione) 3 mg

Write the prescription as "phytonadione 3 mg" with the specific route of administration (oral, subcutaneous, intramuscular, or intravenous) and frequency clearly specified. The generic name "phytonadione" is the standard pharmaceutical term for vitamin K1 and should be recognized in prescription systems 1.

Prescription Writing Format

When prescribing phytonadione 3 mg, your prescription should include:

  • Drug name: Phytonadione (not "vitamin K")
  • Dose: 3 mg
  • Route: Specify oral (PO), subcutaneous (SC), intramuscular (IM), or intravenous (IV)
  • Frequency: Once daily, twice daily, or as needed based on clinical indication

Example Prescription Formats:

For oral administration:

  • "Phytonadione 3 mg PO once"
  • "Phytonadione 3 mg by mouth once daily"

For parenteral administration:

  • "Phytonadione 3 mg subcutaneous once"
  • "Phytonadione 3 mg IM once"

Route Selection Considerations

Oral administration is preferred when possible 2. The FDA labeling indicates that subcutaneous is the preferred parenteral route when oral is not feasible, with IV or IM administration only when "considered unavoidable" 1.

Route-Specific Guidance:

  • Oral: Safest route, avoids anaphylactoid reactions associated with IV administration 3. The IV formulation can be given orally if tablets are unavailable or cost-prohibitive 4.

  • Subcutaneous: Preferred parenteral route per FDA labeling 1. May cause cutaneous reactions 3.

  • Intravenous: Should be administered very slowly (not exceeding 1 mg per minute) due to risk of anaphylactoid reactions 1, 5.

  • Intramuscular: Alternative parenteral route, commonly used in neonates 1.

Clinical Context for 3 mg Dosing

The 3 mg dose falls within the range for managing warfarin-related over-anticoagulation. For INR 5-10 without bleeding, guidelines recommend 1-2 mg oral phytonadione 2. For higher INRs or specific clinical scenarios, doses up to 2.5-10 mg may be appropriate 1.

Common Pitfalls:

  • Don't write "vitamin K" - use the pharmaceutical name "phytonadione" to ensure proper dispensing
  • Always specify the route - different formulations exist and route affects safety profile
  • Protect from light - note this on the prescription if ordering parenteral formulations 1
  • For IV administration, must specify dilution instructions and slow infusion rate (≤1 mg/min) 1

If your electronic prescribing system doesn't recognize "phytonadione 3 mg," try searching for "phytonadione" alone and then manually entering the 3 mg dose, or search for "vitamin K1" as an alternative search term that may link to phytonadione in the formulary.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.